Huadong Medicine Co., Ltd (SHE:000963)
26.10
-0.05 (-0.19%)
Sep 18, 2026, 3:04 PM CST
Huadong Medicine Market Cap
Huadong Medicine has a market cap or net worth of 45.77 billion as of September 18, 2026. Its market cap has decreased by -38.31% in one year.
Market Cap
45.77B
Enterprise Value
42.73B
Revenue
44.00B
Ranking
n/a
PE Ratio
13.20
Stock Price
26.10
ChartMarket Cap Chart
Since January 2, 2001, Huadong Medicine's market cap has increased from 4.21B to 45.77B, an increase of 987.13%. That is a compound annual growth rate of 9.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 45.77B | -33.69% |
| Dec 31, 2025 | 69.03B | 14.00% |
| Dec 31, 2024 | 60.55B | -16.55% |
| Dec 29, 2023 | 72.56B | -11.60% |
| Dec 30, 2022 | 82.09B | 16.70% |
| Dec 31, 2021 | 70.34B | 51.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zhejiang NHU Company | 81.04B |
| Shanghai Fosun Pharmaceutical (Group) | 53.64B |
| China Resources Sanjiu Medical & Pharmaceutical | 39.67B |
| Shenzhen Salubris Pharmaceuticals | 33.46B |
| Beijing Tongrentang | 31.85B |
| Humanwell Healthcare (Group) | 30.07B |
| Dong-E-E-Jiao | 29.08B |
| Changchun High-Tech Industry (Group) | 29.06B |